Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors

Tumor immunotherapy is considered to be a highlight in cancer treatment in recent years. Indoleamine 2,3-dioxygenase 1 (IDO1) is closely related to the over expression of many cancers, and is therefore a promising target for tumor immunotherapy. To search for novel IDO1-targeting therapeutic agents,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Long-fei, Wang, Yu-wei, Zhao, Jie, Xu, Gui-qing, Yao, Xiao-jun, Li, Yue-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555427/
https://www.ncbi.nlm.nih.gov/pubmed/33101032
http://dx.doi.org/10.3389/fphar.2020.579024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555427/
https://www.ncbi.nlm.nih.gov/pubmed/33101032
http://dx.doi.org/10.3389/fphar.2020.579024

Ejemplares similares